Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (681-690 of 738) with videos related to

Pageof 74
Sort By:
Diabetes Care|November 24, 2019
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL TrialM Angelyn Bethel, Robert J Mentz, Peter Merrill, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 23, 2011
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)Samy I McFarlane, Peter A McCullough, James R Sowers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 23, 2010
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP)Lesley A Stevens, Suying Li, Changchun Wang, et al.
Journal of Hypertension|September 22, 2007
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trialVibha Bhatnagar, Daniel T O'Connor, Nicholas J Schork, et al.
Journal of the American Heart Association|November 2, 2021
Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological DatabaseHidehiro Kaneko, Yuichiro Yano, Hidetaka Itoh, et al.
Nature Medicine|June 24, 2024
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialJohannes F E Mann, Peter Rossing, George Bakris, et al.
Journal of Diabetes and Its Complications|January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, Javed Butler, George L Bakris, et al.
Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.
Kidney International|December 21, 2007
Low birth weight is associated with chronic kidney disease only in menS Li, S-C Chen, M Shlipak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2014
Diabetic kidney disease: a report from an ADA Consensus ConferenceKatherine R Tuttle, George L Bakris, Rudolf W Bilous, et al.
Pageof 74

Showing results (681-690 of 738) with videos related to

Sort By:
Pageof 74
Diabetes Care|November 24, 2019
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL TrialM Angelyn Bethel, Robert J Mentz, Peter Merrill, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 23, 2011
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)Samy I McFarlane, Peter A McCullough, James R Sowers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 23, 2010
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP)Lesley A Stevens, Suying Li, Changchun Wang, et al.
Journal of Hypertension|September 22, 2007
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trialVibha Bhatnagar, Daniel T O'Connor, Nicholas J Schork, et al.
Journal of the American Heart Association|November 2, 2021
Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological DatabaseHidehiro Kaneko, Yuichiro Yano, Hidetaka Itoh, et al.
Nature Medicine|June 24, 2024
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialJohannes F E Mann, Peter Rossing, George Bakris, et al.
Journal of Diabetes and Its Complications|January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, Javed Butler, George L Bakris, et al.
Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.
Kidney International|December 21, 2007
Low birth weight is associated with chronic kidney disease only in menS Li, S-C Chen, M Shlipak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2014
Diabetic kidney disease: a report from an ADA Consensus ConferenceKatherine R Tuttle, George L Bakris, Rudolf W Bilous, et al.
Pageof 74